Citron Delivers Blow to Inovio’s Surging Stock Amid Vaccine Hope

(Bloomberg) -- Inovio Pharmaceuticals Inc.’s meteoric rise on the back of hype for a vaccine to treat the coronavirus drew the ire of noted short-seller Citron Research, as the firm slapped a $2 ta...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.